methylselenic acid has been researched along with Ewing Sarcoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aryee, DN; Kauer, M; Kofler, R; Kontny, U; Kovar, H; Meier, A; Niedan, S; Pötschger, U; Schwentner, R | 1 |
1 other study(ies) available for methylselenic acid and Ewing Sarcoma
| Article | Year |
|---|---|
Suppression of FOXO1 is responsible for a growth regulatory repressive transcriptional sub-signature of EWS-FLI1 in Ewing sarcoma.
Topics: Animals; Antineoplastic Agents; Base Sequence; Binding Sites; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Consensus Sequence; Cyclin-Dependent Kinase 2; Forkhead Box Protein O1; Forkhead Box Protein O3; Forkhead Transcription Factors; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Mice; Oncogene Proteins, Fusion; Organoselenium Compounds; Phosphorylation; Promoter Regions, Genetic; Protein Processing, Post-Translational; Protein Transport; Proto-Oncogene Protein c-fli-1; Proto-Oncogene Proteins c-akt; RNA-Binding Protein EWS; Sarcoma, Ewing; Transcription, Genetic; Tumor Burden; Xenograft Model Antitumor Assays | 2014 |